BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 4307059)

  • 1. [A comparative study of the antigenic and immunogenic properties of the anatoxin of Cl. perfringens, concentrated and purified by various methods].
    Larina IA; Samsonova VS; Volkova ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):86-9. PubMed ID: 4309741
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathomorphologic and histochemical changes caused by a culture of type A Cl. perfringens in guinea pigs immunized with analecithinase].
    Anosov IIa; Larina IA; Ispolatovskaia MV
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):136-9. PubMed ID: 5735222
    [No Abstract]   [Full Text] [Related]  

  • 3. [The experimental validation of methods for the emergency immunoprophylaxis of gas gangrene].
    Sergeeva TI; Chirikova EV; Babaĭtseva VA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):9-13. PubMed ID: 8525744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective properties of theta-hemolysin obtained by affinity chromatography].
    Efimova MG; Blagoveshchenskiĭ VA; Khatuntseva BV
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Dec; (12):87-92. PubMed ID: 6297191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunogenic properties of Cl. perfringens anatoxins obtained from purified toxins].
    Dmitrieva LN; Shemanova GF; Akhundova KA; Vlasova EV; Il'nitskaia KA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Nov; (11):134-6. PubMed ID: 176848
    [No Abstract]   [Full Text] [Related]  

  • 6. Clostridium perfringens toxins (type A, B, C, D, E).
    McDonel JL
    Pharmacol Ther; 1980; 10(3):617-55. PubMed ID: 6255496
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccines against Clostridium perfringens alpha-toxin.
    Nagahama M
    Curr Pharm Biotechnol; 2013; 14(10):913-7. PubMed ID: 24372250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium perfringens vaccines.
    Titball RW
    Vaccine; 2009 Nov; 27 Suppl 4():D44-7. PubMed ID: 19837285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Clostridium perfringens phospholipase C in the pathogenesis of gas gangrene.
    Flores-Díaz M; Alape-Girón A
    Toxicon; 2003 Dec; 42(8):979-86. PubMed ID: 15019495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The outlook for creating a single system for the immunoprophylaxis of clostridial wound infections].
    Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):111-6. PubMed ID: 7992520
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the role of lecithinase C in creating immunity to gas gangrene under experimental conditions].
    Larina IA; Ispolatovskaia MV
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jul; 43(7):125-9. PubMed ID: 4307059
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.